PE20070178A1 - PIRAZOLINE COMPOUNDS AS CANNABINOID RECEPTOR MODULATORS - Google Patents
PIRAZOLINE COMPOUNDS AS CANNABINOID RECEPTOR MODULATORSInfo
- Publication number
- PE20070178A1 PE20070178A1 PE2006000850A PE2006000850A PE20070178A1 PE 20070178 A1 PE20070178 A1 PE 20070178A1 PE 2006000850 A PE2006000850 A PE 2006000850A PE 2006000850 A PE2006000850 A PE 2006000850A PE 20070178 A1 PE20070178 A1 PE 20070178A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- pyrazole
- dichloro
- dihydro
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DE PIRAZOLINA DE FORMULA (I), EN DONDE R1 Y R2 SON INDEPENDIENTEMENTE FENILO NO SUSTITUIDO O AL MENOS MONOSUSTITUIDO CON -CF3, -C2F5, C3F7, ENTRE OTROS; R3 ES CICLONONILO, CICLODECILO, CICLOUNDECILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS. SON PREFERIDOS: (HEXAHIDRO-CICLOPENTA[c]PIRROL-2-IL)-AMIDA DEL ACIDO 5-(4-CLORO-FENIL)-1-(2,4-DICLORO-FENIL)-4,5-DIHIDRO-1H-PIRAZOL-3-CARBOXILICO, [2-(S)-(1-METOXI-1METIL-ETIL)-PIRROLIDIN-1-IL]-AMIDA DEL ACIDO 5-(4-CLORO-FENIL)-1-(2,4-DICLORO-FENIL)-4,5-DIHIDRO-1H-PIRAZOL-3-CARBOXILICO, [2-(R)-(1-METOXI-1METIL-ETIL)-PIRROLIDIN-1-IL]-AMIDA DEL ACIDO 5-(4-CLORO-FENIL)-1-(2,4-DICLORO-FENIL)-4,5-DIHIDRO-1H-PIRAZOL-3-CARBOXILICO, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON MODULADORES SELECTIVOS DE RECEPTORES DE CANNABINOIDES 1 (CB1) ES DECIR SON ANTAGONISTAS, AGONISTAS INVERSOS O AGONISTAS. Y SON UTILES PARA EL TRATAMIENTO DE TRANSTORNOS DE SISTEMA NERVIOSO CENTRAL, INMUNITARIO, CARDIOVASCULAR, ENDOCRINO, TRACTO GASTROINTESTINALIT REFERS TO PYRAZOLINE COMPOUNDS OF FORMULA (I), WHERE R1 AND R2 ARE INDEPENDENTLY PHENYL NOT SUBSTITUTED OR AT LEAST MONOSTITUTED WITH -CF3, -C2F5, C3F7, AMONG OTHERS; R3 IS CYCLONONIL, CYCLODECYL, CYCLOUNDECILO, AMONG OTHERS, OPTIONALLY SUBSTITUTED. PREFERRED: (HEXAHYDRO-CYCLOPENTA [c] PYRROL-2-IL) -AMIDE OF THE ACID 5- (4-CHLORO-PHENYL) -1- (2,4-DICHLORO-PHENYL) -4,5-DIHYDRO-1H- PYRAZOLE-3-CARBOXYL, [2- (S) - (1-METOXY-1-METHYL-ETHYL) -PYRROLIDIN-1-IL] -AMIDE OF THE ACID 5- (4-CHLORO-PHENYL) -1- (2,4- DICHLORO-PHENYL) -4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYL, [2- (R) - (1-METHOXY-1-METHYL-ETHYL) -PYRROLIDIN-1-IL] -AMIDE OF THE ACID 5- (4 -CHLORO-PHENYL) -1- (2,4-DICHLORO-PHENYL) -4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYL, AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION AND A PREPARATION PROCEDURE. THESE COMPOUNDS ARE SELECTIVE MODULATORS OF CANNABINOID 1 (CB1) RECEPTORS, THAT IS, THEY ARE ANTAGONISTS, INVERSE AGONISTS OR AGONISTS. AND THEY ARE USEFUL FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM, IMMUNE, CARDIOVASCULAR, ENDOCRINE, GASTROINTESTINAL TRACT DISORDERS
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05384018A EP1743888A1 (en) | 2005-07-15 | 2005-07-15 | Carbonyl substituted pyrazoline compounds, their preparation and use as CB1 receptor modulators |
US70543305P | 2005-08-05 | 2005-08-05 | |
EP06008579A EP1849783A1 (en) | 2006-04-26 | 2006-04-26 | Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments |
EP06008612A EP1849776A1 (en) | 2006-04-26 | 2006-04-26 | Azepane- or Azocane-substituted pyrazoline compounds, their preparation and use as medicaments |
EP06008580A EP1849775A1 (en) | 2006-04-26 | 2006-04-26 | Cycloalkane-substituted pyrazoline compounds, their preparation and use as medicaments |
EP06008581A EP1849784A1 (en) | 2006-04-26 | 2006-04-26 | Indoline-substituted pyrazoline compounds, their preparation and use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070178A1 true PE20070178A1 (en) | 2007-04-04 |
Family
ID=43298612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000850A PE20070178A1 (en) | 2005-07-15 | 2006-07-14 | PIRAZOLINE COMPOUNDS AS CANNABINOID RECEPTOR MODULATORS |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR062543A1 (en) |
PE (1) | PE20070178A1 (en) |
TW (1) | TW200738640A (en) |
-
2006
- 2006-07-14 PE PE2006000850A patent/PE20070178A1/en not_active Application Discontinuation
- 2006-07-14 TW TW095125891A patent/TW200738640A/en unknown
- 2006-07-14 AR ARP060103040A patent/AR062543A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR062543A1 (en) | 2008-11-19 |
TW200738640A (en) | 2007-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20051140A1 (en) | SUBSTITUTE PIRAZOLINE COMPOUNDS AND THEIR PREPARATION AS MEDICINES | |
NO20052728L (en) | Substituted tricyclic gamma-carbolines such as serotonin receptor agonists and antagonists | |
DE602005020655D1 (en) | Carboxamide-spirolactam CGRP Receptor Antagonists | |
EA200900828A1 (en) | COMPOUNDS AND COMPOSITIONS AS AN INHIBITOR ACTIVITY OF THE CANANABINOID RECEPTOR 1 | |
MY161834A (en) | Substituted diazepan compounds as orexin receptor antagonists | |
DK2049529T3 (en) | Substituted diazepan-orexin receptor antagonists | |
EA200800430A1 (en) | SUBSTITUTED TETRAHYDRO-1H-PYRIDO [4.3, B] INDOLS AS AGONISTS AND ANTAGONISTS OF SEROTONIN RECEPTORS | |
RS20080411A (en) | Amine derivatives | |
MX2008002805A (en) | Carboxamide derivatives as muscarinic receptor antagonists. | |
PE20070194A1 (en) | 4-SUBSTITUTED PIRAZOLINE COMPOUNDS AS CB1 MODULATORS | |
DK2081572T3 (en) | Benzimidazole cannabinoid agonists with a substituted heterocyclic group | |
WO2009013212A3 (en) | Dual modulators of 5-ht2a and d3 receptors | |
ATE486071T1 (en) | AZABICYCLOÄ3.1.0ÜHEXANE DERIVATIVES AS MODULATORS OF THE DOPAMINE D3 RECEPTOR | |
EA200501595A1 (en) | AZABICYCLIC DERIVATIVES AS ANTAGONISTS OF MUSCARINE RECEPTOR | |
MX2007004661A (en) | 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists. | |
MX2010003849A (en) | Cgrp antagonists. | |
ATE407120T1 (en) | 3-((HETERO)ARYLSULFONYL)-8-Ä(AMINOALKYL)OXYQUINOLINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR FOR THE TREATMENT OF CNS DISEASES | |
ECSP088948A (en) | 4-METHYL-1H-PIRROL-2-CARBOXAMIDS 1,3-DISUSTITUTED AND ITS USE FOR THE PRODUCTION OF MEDICINES | |
ATE399156T1 (en) | NEW INDOLE OR BENZIMIDAZOLE DERIVATIVES | |
MX2010001195A (en) | Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors. | |
UA84035C2 (en) | Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists | |
EA200600060A1 (en) | AMINOSULPHONYL SUBSTITUTED 4- (AMINOMETHIL) PIPERIDINBENZAMIDES AS 5HT ANTAGONISTS | |
EA200501594A1 (en) | SUBSTITUTED DERIVATIVES OF AZABICOLOGEXANE AS ANTAGONISTS OF MUSCARINE RECEPTOR | |
PE20070178A1 (en) | PIRAZOLINE COMPOUNDS AS CANNABINOID RECEPTOR MODULATORS | |
ATE461172T1 (en) | AZETIDINE DERIVATIVES AS ANTAGONISTS OF THE MUSCARIINE RECEPTOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |